USFDA approved the pharmaceutical company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg.
Marksans Pharma receives USFDA approval for Loratadine Tablets USP 10 mg, expanding its generic drug portfolio.